Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Clinical Study on the Safety, Tolerability, Pharmacokinetics, and Efficacy of STR-P005 in the Treatment of Relapsed/Refractory Autoimmune Diseases

NCT07655453 is registered in ClinicalTrials.gov with Starna Therapeutics as lead sponsor.

NCT NCT07655453
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07655453 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Clinical Study on the Safety, Tolerability, Pharmacokinetics, and Efficacy of STR-P005 in the Treatment of Relapsed/Refractory Autoimmune Diseases
Lead sponsor
Starna Therapeutics
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
July 30, 2028
Enrollment
36 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

relapsed/refractory autoimmune diseases